Teva's problem - Bad can get worse
Sometimes a stock is a better sell at a lower price than it was at the prior, higher price range; that might the case for Teva Pharmaceutical (NYSE:TEVA) now. This happened to me in the spring of 2014 with an oil driller, Tidewater (NYSE:TDW). I managed to lose 10% in the stock just as I was transitioning from bullish on the shale revolution to bearish on oil prices. I bought TDW around $55 and sold near $50 pre-split. Now it is at $27 post-split. The split? It was a reverse split, where 1000 shares turned into only 31 shares. If I had not sold at $50, I would have essentially lost all my money in the stock. This was one of the few times where I lost money in a stock and felt grateful that I made a very good decision. I had made lots of money in energy plays between 2010 and 2014, and one loss was just the price of playing the game.
